Implantable passive mean pressure sensor

Information

  • Patent Grant
  • 12329500
  • Patent Number
    12,329,500
  • Date Filed
    Monday, November 29, 2021
    3 years ago
  • Date Issued
    Tuesday, June 17, 2025
    4 months ago
Abstract
An implantable pressure sensor includes a housing and a sensing component that is housed by the housing and exposed to an external pressure that is exterior to the housing. In response to the external pressure, the sensing component is configured to undergo a physical transformation that is representative of a mean pressure of the external pressure over a period of time of at least one minute. The pressure sensor includes circuitry that is operatively coupled to the sensing component and that is responsive to the physical transformation of the sensing component to produce a mean pressure signal that is representative of the mean pressure of the external pressure over the period of time.
Description
TECHNICAL FIELD

The present disclosure pertains to pressure sensors. More particularly, the present disclosure pertains to implantable pressure sensors that can provide a mean pressure indication.


BACKGROUND

A variety of pressure sensors have been developed for measuring a variety of different pressures, including blood pressure. Some pressure sensors may be implanted in the body in order to provide blood pressure values. Because they are implanted, there can be issues with being able to provide power to the pressure sensor over time. Moreover, while pressure sensors can provide an instantaneous indication of pressure, they typically are not configured to provide an indication of mean pressure over time. There is an ongoing need for a pressure sensor that can provide an indication of mean pressure over time, particularly without requiring ongoing electrical energy in order to maintain a measurement of mean pressure over time.


SUMMARY

This disclosure pertains to pressure sensors that can provide an indication of mean pressure over time, even without ongoing electrical energy to maintain the indication of mean pressure over time. As an example, an implantable pressure sensor includes a housing and a sensing component that is housed by the housing and exposed to an external pressure that is exterior to the housing. In response to the external pressure, the sensing component is configured to undergo a physical transformation that is representative of a mean pressure of the external pressure over a period of time of at least one minute. The pressure sensor includes circuitry that is operatively coupled to the sensing component and that is responsive to the physical transformation of the sensing component to produce a mean pressure signal that is representative of the mean pressure of the external pressure over the period of time.


Alternatively or additionally, the circuitry may be configured to repeatedly receive an energy transfer from a remote source, and in response, transmit the mean pressure signal back to the remote source.


Alternatively or additionally, the sensing component may undergo and maintain the physical transformation that is representative of the mean pressure of the external pressure over the period of time without the application of electrical power.


Alternatively or additionally, the physical transformation of the sensing component may have a time constant of at least one hour.


Alternatively or additionally, the physical transformation of the sensing component may have a time constant of at least twelve hours.


Alternatively or additionally, the physical transformation of the sensing component may have a time constant of at least 1 day.


Alternatively or additionally, the housing may be adapted for being disposed within a patient's heart, bladder, brain, spinal column, eye, joint or vascular system.


Alternatively or additionally, the sensing component may include a first plate exposed to the external pressure exterior to the housing and configured to move in response to pressure changes within the external pressure, a second plate spaced apart from the first plate and disposed within the housing, and a viscoelastic material disposed between the first plate and the second plate.


Alternatively or additionally, the viscoelastic material may include a non-conductive material, and the mean pressure signal may be representative of a capacitance between the first plate and the second plate.


Alternatively or additionally, the viscoelastic material may include an electrically conductive material, and the mean pressure signal may be an indication of a resistance between the first plate and the second plate.


Alternatively or additionally, the first plate may be electrically conductive and the second plate may be electrically conductive.


Alternatively or additionally, the sensing component may include a hydraulic sensing component.


Alternatively or additionally, the hydraulic sensing component may include a hydraulic chamber exposed to the external pressure, a first fluid disposed within the hydraulic chamber, a pressure chamber, a second fluid disposed within the pressure chamber, and a barrier disposed between the first fluid and the second fluid. Pressure changes in the hydraulic chamber relative to a pressure within the pressure chamber may cause movement of the barrier.


Alternatively or additionally, the barrier may include a low flow valve with a high permeability material.


As another example, an implantable pressure sensor is configured to provide a signal providing an indication of a mean pressure value over a period of time. The implantable pressure sensor includes a housing configured to be implanted in a patient and a sensing component disposed within the housing yet exposed to an environment exterior to the housing. The sensing component is configured to maintain a mean pressure measurement providing an indication of a mean pressure within the environment exterior to the housing over a period of time without electrical energy.


Alternatively or additionally, the sensing component may include a viscoelastic material having a time constant of at least one hour.


As another example, a left atrial appendage closure device is adapted to fit within a patient's left atrial appendage in order to substantially close off the patient's left atrial appendage. The left atrial appendage closure device includes an expandable framework. A sensing component is exposed to a left atrium pressure within the left atrium of the patient's heart once the left atrial appendage closure device is implanted, wherein in response to the left atrium pressure, the sensing component is configured to undergo a physical transformation that is representative of a mean pressure of the left atrium pressure over a period of time of at least 1 minute. Circuitry is operatively coupled to the sensing component and is responsive to the physical transformation of the sensing component to produce a mean pressure signal that is representative of the mean pressure of the left atrium pressure over the period of time.


Alternatively or additionally, the sensing component may include a viscoelastic material with a time constant of at least 10 minutes that, in response to the left atrium pressure, viscoelastically deforms in a manner that represent the mean pressure of the left atrium pressure over the period of time.


Alternatively or additionally, the sensing component may include a hydraulic system including a low flow valve, wherein in response to a positive change in the left atrium pressure, the sensing component moves fluid through the low flow valve under a hydraulic resistance in a first direction subject to a time constant of the sensing component defined at least in part by the low flow valve.


Alternatively or additionally, in response to a negative change in the left atrium pressure, the sensing component may move fluid through the low flow valve in a second direction opposite to the first direction subject to the time constant of the sensing component.


The above summary of some embodiments is not intended to describe each disclosed embodiment or every implementation of the present disclosure. The Figures, and Detailed Description, which follow, more particularly exemplify these embodiments.





BRIEF DESCRIPTION OF THE DRAWINGS

The disclosure may be more completely understood in consideration of the following detailed description in connection with the accompanying drawings, in which:



FIG. 1 is a schematic block diagram of an illustrative pressure sensing system;



FIG. 2 is a schematic diagram of an illustrative pressure sensor;



FIG. 3 is a graphical representation of mean pressure data;



FIG. 4 is a schematic diagram of an illustrative pressure sensor;



FIG. 4A is a schematic diagram of a portion of an illustrative pressure sensor;



FIG. 4B is a schematic diagram of a portion of an illustrative pressure sensor;



FIG. 5 is a perspective view of an illustrative left atrial appendage closure device; and



FIG. 6 is a side view of the illustrative left atrial appendage closure device of FIG. 5.





While the disclosure is amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit the invention to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the disclosure.


DESCRIPTION

For the following defined terms, these definitions shall be applied, unless a different definition is given in the claims or elsewhere in this specification.


All numeric values are herein assumed to be modified by the term “about”, whether or not explicitly indicated. The term “about” generally refers to a range of numbers that one of skill in the art would consider equivalent to the recited value (e.g., having the same function or result). In many instances, the terms “about” may include numbers that are rounded to the nearest significant figure.


The recitation of numerical ranges by endpoints includes all numbers within that range (e.g. 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, and 5).


As used in this specification and the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the content clearly dictates otherwise. As used in this specification and the appended claims, the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise.


It is noted that references in the specification to “an embodiment”, “some embodiments”, “other embodiments”, etc., indicate that the embodiment described may include one or more particular features, structures, and/or characteristics. However, such recitations do not necessarily mean that all embodiments include the particular features, structures, and/or characteristics. Additionally, when particular features, structures, and/or characteristics are described in connection with one embodiment, it should be understood that such features, structures, and/or characteristics may also be used connection with other embodiments whether or not explicitly described unless clearly stated to the contrary.


The following detailed description should be read with reference to the drawings in which similar elements in different drawings are numbered the same. The drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the invention.



FIG. 1 is a schematic block diagram of an illustrative pressure sensing system 10. The pressure sensing system 10 includes a pressure sensor 12 and a remote energy source 20. The pressure sensor 12 may be configured to be implanted within a patient's body. In some cases, the pressure sensor 12 may be configured to be implanted at a location in which the pressure sensor 12 may be exposed to the patient's blood, such as within the patient's vasculature. For example, the pressure sensor 12 may be configured to be implanted within a chamber of the patient's heart. In other cases, the pressure sensor 12 may be configured to be implanted within a patient's bladder, artery, vein, brain, spinal column, eye, joint or other location, for example.


The illustrative pressure sensor 12 includes a housing 16 that is configured to be implanted at a desired location within the patient. While the pressure sensor 12 is described herein as being deployed as an implantable device, intended for use in the human body, it will be appreciated that the pressure sensor 12 may be applied to other applications as well. When intended for use in the human body, the housing 16 may be formed of any suitable biocompatible material, such as a biocompatible polymeric material or a biocompatible metallic material. In some cases, the housing 16 may be formed of a material that is not biocompatible, but may have a biocompatible film or coating covering an exterior of the housing 16.


The pressure sensor 12 may be considered as being configured to provide an indication of a mean pressure, or an average pressure value over time. The mean pressure may be rolling mean pressure taken over a predetermined time horizon. That is, rather than an instantaneous pressure sensor that immediately reports a currently detected pressure, the pressure sensor 12 creates and maintains a mean pressure measurement that is not overly influenced by transient spikes in pressure. For example, a person's blood pressure may spike while they are climbing stairs, or otherwise exerting themselves. An instantaneous blood pressure measurement, especially when taken only at certain time intervals, may not provide an accurate picture of the person's overall cardiovascular health. In contrast, a mean blood pressure measurement may do a better job of ignoring short term pressure spikes to more accurately represent an overall blood pressure trend.


The illustrative pressure sensor 12 includes a sensing component 18. The sensing component 18 may be configured to create and maintain an indication of mean pressure that represents a mean pressure of the environment outside of the housing 16 over time. To that end, the housing 16 may be configured to allow the sensing component 18 or at least a portion thereof to be exposed to the environment outside of the housing 16. In some cases, the sensing component 18 may include a viscoelastic material. A viscoelastic material is a material for which the relationship between stress and strain depends on time, and that includes properties of both viscous and elastic materials. Viscosity is a measure of a fluid's resistance to flow while elasticity is a measure of a material's ability to return to its original shape after application of a force. Sorbothane®, which is a highly damped viscoelastic polymeric solid that flows like a liquid under load is one example viscoelastic material. Sorbothane® is a thermoset, polyether-based, polyurethane material. Memory foam is another example viscoelastic material. Other example viscoelastic materials include some polymers, semi-crystalline polymers, biopolymers, neoprene, and bitumen materials. These materials can be tailored to have a desired time constant to match the desired application.


Rather than using a viscoelastic material, the sensing component 18 may be implemented as a hydraulic system that can track a mean or rolling average of pressure over time. Other systems may also be used. In any event, the sensing component 18 may be considered as being configured to maintain an indication of mean pressure over time without needing any source of electricity to create and maintain the indication of mean pressure. As a result, the pressure sensor 12 does not need any on-board source of power, such as a battery. Rather, the pressure sensor 12 may be configured to periodically receive power transmitted from a remote power source 20. In order for the pressure sensor 12 to be able to receive and utilize the power transmitted from the remote power source 20, the pressure sensor 12 includes circuitry 22 that is operably coupled to the sensing component 18.


The illustrative circuitry 22 includes an antenna 24 that is configured to receive electrical energy from the remote power source 20. The circuitry 22 is configured to convert the electrical energy into an appropriate form, if appropriate, and to use the energy to solicit a signal from the sensing component 18. The circuitry 22 then transmits the signal that provides an indication of the mean pressure measured over time by the sensing component 18 to a remote monitoring device 26. In some cases, a single antenna 24 is able to both receive electrical energy transmitted by the remote power source 20 and to communicate with the remote monitoring device 26. In some instances, the antenna 24 may instead represent a first antenna that is configured to receive electrical energy transmitted by the remote power source 20 and a second antenna that is configured to transmit a signal to the remote monitoring device 26. While the remote power source 20 and the remote monitoring device 26 are illustrated as being separate devices, it will be appreciated that in some cases the remote power source 20 and the remote monitoring device 26 may be incorporated into a single hand-held apparatus.


It should be noted that the electrical energy provided to the pressure sensor 12 from the remote power source 20 is not used to create or maintain an indication of a mean pressure measurement over time. Rather, the indication of the mean pressure measurement over time is created and maintained over time by the sensing component 18 without need for ongoing electrical energy. In this example, the electrical energy provided by the remote power source 20 is only used to query the sensing component 18 for an indication of the mean pressure measurement over time and to transmit a signal representing the indication of the mean pressure measurement over time to the remote monitoring device 26.


In some cases, the sensing component 18 may be considered as having being configured to undergo a physical transformation in response to being exposed to an external pressure outside of the housing 16. The physical transformation may be considered as being representative of a mean pressure of the external pressure over a period of at least one minute. Brief spikes in pressure may be largely ignored. The physical transformation of the sensing component 18 may be considered as having a time constant of at least one hour. The physical transformation of the sensing component 18 may be considered as having a time constant of at least twelve hours. The physical transformation of the sensing component 18 may be considered as having a time constant of at least one day. The time constant here represents the speed at which the sensing component 18 can respond to a change in input pressure, defined here as the time for the mean pressure reported by the sensing component 18 to vary by a factor of 1−1/e (approximately 0.6321) in response to a step change in input pressure. That is, for a time constant of one day, when the input pressure P is halved to P/2 at time “t” and is maintained at P/2 for a day, the sensing component 18 would report a mean pressure of P−(P/2*(1−1/e))≈0.68P after one day. This is just an example.


In some cases, a time constant for increased pressure (e.g. a compression time constant) may be configured to be about equal to a time constant for decreased pressure (e.g. expansion time constant) to facilitate the measurement of a mean pressure measurement. In some cases, the time constant for increased pressure and the time constant for decreased pressure may not be equal. For example, there may be a desire to bias the measurement towards higher or lower pressures, or when both time constants are adjusted to account for biological effects (e.g. tissue encapsulation).


In some cases, the signal provided by the circuitry 22, which is representative of the mean pressure measurement provided by the sensing component 18, may be corrected for sensor hysteresis. This correction may occur within the remote monitoring device 26 in order to reduce the computational requirements for the circuitry 22, although in some cases the circuitry 22 may itself correct for sensor hysteresis. In some instances, a second or additional pressure sensor(s) (not illustrated) may also be implanted within a patient in order to provide an instantaneous measurement when desired, in addition to the mean pressure measurement provided by the pressure sensor 12. The second or additional pressure sensor(s) may be part of the pressure sensor 12 and operatively coupled to the circuitry 22. Alternatively, the additional pressure sensor(s) may be separately housed. The additional pressure sensor(s) may be used to calibrate the pressure sensor 12. Alternatively, the pressure sensor 12 may be used to calibrate the instantaneous pressure sensor. It will be appreciated that the pressure sensor 12 (and any additional pressure sensors) may be configured to operate within the range of pressures that are encountered within a vessel or chamber within the human body. For example, the expected absolute pressure range within the left atrium is 450 to 950 millimeters (mm) Hg. The expected gauge pressure within the left atrium is 2 to 90 mm Hg.



FIG. 2 is a schematic diagram of an illustrative pressure sensor 28 that is exposed to an environment 30 having a variable pressure. The pressure sensor 28 may be considered as an example of the pressure sensor 12. The environment 30 may represent part of the patient's vasculature, including their heart, or the patient's bladder or other cavity. The illustrative pressure sensor 28 includes a chamber 32 that is formed between a first plate 34 and a second plate 36. A housing 38, which may be considered as illustrative of the housing 16 shown in FIG. 1, may provide sides and a bottom to the chamber 32. The first plate 34 is positioned such that changes in pressure within the environment 30 may cause the first plate 34 to flex downward (in the illustrated orientation) when the external pressure within the environment 30 increases, and may cause the first plate 34 to flex upward (in the illustrated orientation) when the external pressure within the environment 30 decreases. In this example, the chamber 32 is filled with a viscoelastic material 40.


The first plate 34 and the second plate 36 may be considered as being electrically conductive. In some cases, when the viscoelastic material 40 is not electrically conductive, the physical transformations that have occurred over time to the viscoelastic material 40 may be indicated by detecting a capacitance between the first plate 34 and the second plate 36. In other cases, when the viscoelastic material 40 is electrically conductive, the physical transformations that have occurred over time to the viscoelastic material 40 may be indicated by detecting a resistance between the first plate 34 and the second plate 36. These are just examples.



FIG. 3 is a graphical representation 50 of how a viscoelastic material may be used to track a mean pressure measurement over time. This particular example tracks left atrial pressure over a time period of five weeks, with the left atrial pressure indicated on the vertical axis while time is indicated on the horizontal axis. This pressure data is not actual pressure data taken from a patient, but rather has been generated to illustrative how a mean pressure measurement over time is able to ignore transient spikes and missed measurements. While this example is specific to use of a viscoelastic material as part of the sensing component 18, it will be appreciated that the lessons taught by this example are equally applicable to other types of the sensing component 18, such as a hydraulic or other system.


A graphed line 52 shows a mean left atrial pressure as determined by periodic instantaneous measurements 56. In some cases, the graphed line 52 indicates that the mean left atrial pressure as determined by periodic instantaneous measurements 56 can be skewed if the instantaneous measurements are taken at a bad time (e.g. at a short term peak). For example, several periodic instantaneous measurements 58 show left atrial pressure values that are high due to a condition that interferes with the desired mean pressure measurement, such as when an instantaneous measurement was taken while the person was exercising. The graphed line 52 also shows that the mean left atrial pressure as determined by periodic instantaneous measurements may be skewed if instantaneous measurements are missing, such as the missed samples 60. A graphed line 62 provides a representation of the patient's actual left atrial pressure. It can be seen that the graphed line 62 passes through each of the periodic instantaneous measurements 56, the badly timed instantaneous measurements 58 and the missed instantaneous measurements 60. It can be seen that the actual pressure can periodically spike.


A graphed line 64 provides a representation of the mean left atrial pressure as determined using a viscoelastic material. It can be seen that the graphed line 64 overall tracks the actual left atrial pressure as indicated by the graphed line 62, and the graphed line 64 is not influenced by the poorly timed instantaneous measurements 58 or by the missed instantaneous measurements 60. This illustrates how the mean pressure measurement may be used as a reliable indication of blood pressure performance without requiring frequent instantaneous measurements. This also illustrates how a viscoelastic material may be used to provide an indication of mean pressure over time in a manner that does not require electrical energy to either create or maintain the indication of mean pressure over time.



FIG. 4 is a schematic diagram of an illustrative pressure sensor 70 that is exposed to an environment 30 having a variable pressure. The pressure sensor 70 may be considered as an example of the pressure sensor 12, and may operate hydraulically. The pressure sensor 70 includes a hydraulic chamber 72 that is exposed to the external pressure within the environment 30. The hydraulic chamber 72 includes a chamber wall 74 that is configured to bend and flex in response to relative pressure differences between the environment 30 and the hydraulic chamber 72. The hydraulic chamber 72 includes a first fluid. The pressure sensor 70 includes a pressure chamber 76 that includes a second fluid. The second fluid may be the same as the first fluid. In some cases, the first fluid may be a liquid. In some cases, the second fluid may be a liquid. A barrier 78 is fluidly coupled between the hydraulic chamber 72 and the pressure chamber 76. The hydraulic chamber 72 may be considered as acting as a movement multiplier, such that relatively small pressure differences between the environment 30 and the hydraulic chamber 72 result in detectable movement of the barrier 78.


In the example shown, the barrier 78 includes a low flow valve with a high permeability material. As the external pressure within the environment 30 changes, the barrier 78 fluidly disposed between the hydraulic chamber 72 and the pressure chamber 76 moves in response thereto. Also, a maintained external pressure causes some of the fluid to slowly flow through the low flow valve, moving between the hydraulic chamber 72 and the pressure chamber 76. The rate of flow through the low flow valve of the barrier 78 may be chosen to set the time constant of the pressure sensor 70. This physical transformation of the barrier 78 and movement of the fluid between the hydraulic chamber 72 and the pressure chamber 76 is representative of the mean external pressure. To read the mean pressure value, a coil 80 may be coupled with the barrier 78. As the barrier 78 moves in response to pressure changes, the inductance of the coil 80 will change. Accordingly, measuring the inductance of the coil 80 may provide an indication of the mean pressure measurement when the hydraulic chamber 72, the pressure chamber 76 and the fluids therein are non-conductive.



FIG. 4A illustrates a version of the pressure sensor 70 in which capacitance is used to provide an indication of mean pressure. In FIG. 4A, a first plate 90 and a second plate 92 are conductive and function as the barrier 78 (FIG. 4) with a low flow valve. In some cases, the first plate 90 moves in response to changes in mean pressure while the second plate 92 does not. As the distance between the first plate 90 and the second plate 92 varies in accordance with pressure changes, the capacitance between the first plate 90 and the second plate 92 may be used as an indication of the mean pressure measurement. In FIG. 4A, the first and second fluids are electrically non-conductive or substantially electrically non-conductive. In this, substantially electrically non-conductive means that the fluids are not sufficiently electrically conductive to interfere with a capacitance measurement. In FIG. 4B, electrically conductive liquids are used, and changes in resistance between the first plate 90 and the second plate 92 may be used as an indication of the mean pressure measurement.



FIG. 5 is a perspective view of an illustrative left atrial appendage closure device 100 while FIG. 6 is a side view thereof showing the left atrial appendage closure device 100 including an occlusive element 104. The left atrial appendage closure device 100 includes an expandable framework 102 that is configured to convert between a collapsed configuration (for delivery) and an expanded configuration, as shown. In some instances, the expandable framework may be compliant and may substantially conform to and/or be in sealing engagement with the shape and/or geometry of a lateral wall and/or an ostium of a left atrial appendage in the expanded configuration. The left atrial appendage closure device 100 may expand to a size, extent, or shape less than or different from a maximum unconstrained extent, as determined by the surrounding tissue and/or lateral wall of the left atrial appendage. Reducing a thickness of various elements of the expandable framework 102 may increase the flexibility and compliance of the expandable framework 102 and/or the left atrial appendage closure device 100, thereby permitting the expandable framework 102 and/or the left atrial appendage closure device 100 to conform to the tissue around it, rather than forcing the tissue to conform to the expandable framework 102 and/or the left atrial appendage closure device 100.


In some cases, as shown in FIG. 6, the left atrial appendage closure device 100 may optionally include an occlusive element 104 (e.g., a mesh, a fabric, a membrane, and/or other surface treatment) disposed on, disposed over, disposed about, or covering at least a portion of the expandable framework 102. In some embodiments, the occlusive element 104 may be disposed on, disposed over, disposed about or cover at least a portion of an outer (or outwardly facing) surface of the expandable framework 102.


In some embodiments, the expandable framework 102 may include a plurality of anchor members 106 disposed about a periphery of the expandable framework 102 in the expanded configuration. The plurality of anchor members 106 may extend radially outward from the expandable framework 102. In some embodiments, at least some of the plurality of anchor members 106 may each have and/or include a body portion, a tip portion, and a barb projecting circumferentially therefrom. In some embodiments, some and/or each of the plurality of anchor members 106 have at least one barb projecting circumferentially therefrom. The plurality of anchor members 106 may provide an anchoring mechanism to aid in retaining the left atrial appendage closure device 100 at a target site within a patient's anatomy (i.e., the left atrial appendage, for example) in the expanded configuration. However, the barb(s) may be configured, positioned, and/or arranged such that engagement of the barb(s) with surrounding tissue at the target site is minimized. For example, the barb(s) may not puncture, pierce, and/or extend into the surrounding tissue in the expanded configuration. Additionally, in some embodiments, the plurality of anchor members 106 may provide an attachment mechanism for securing the occlusive element 104 to the expandable framework 102.


The left atrial appendage closure device 100 may include a central post 108 from which at least some components of the expandable framework 102 may extend. In some instances, as best seen in FIG. 6, the central post 108 may include a pressure sensor 110 disposed within the central post 108. In this, the central post 108 may function at least in part as a housing for the pressure sensor 110. While shown schematically, the pressure sensor 110 may represent the pressure sensor 12 shown in FIG. 1. The pressure sensor 110 may represent the pressure sensor 28 shown in FIG. 2. The pressure sensor 110 may represent the pressure sensor 70 shown in FIG. 4. It will be appreciated that by placing the pressure sensor 110 within the central post 108, or securing the pressure sensor 110 to any other portion of the left atrial appendage closure device 100, it is possible to obtain a mean left atrial pressure measurement over time of the left atrium. In some cases, the pressure sensor 110 may extend a substantial portion of the length of the central post 108, but this is not required.


Because endothelization makes removal of the left atrial appendage closure device 100 difficult, having a pressure sensor such as the pressure sensor 110 that can provide an indication of mean left atrial blood pressure over time, without requiring any onboard power supply, means that there are no concerns with battery life, for example. A doctor or other medical professional can simply use the remote power source 20 (FIG. 1) to periodically provide sufficient power for the circuitry within the power sensor 110 to ascertain a mean left atrial blood pressure measurement as indicated by whatever sensing component is present within the pressure sensor 110. This mean left atrial blood pressure measurement may be communicated to the remote monitoring device 26 and used for by a physician or the like in monitoring, diagnosing and/or treating the patient.


It should be understood that this disclosure is, in many respects, only illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of steps without exceeding the scope of the disclosure. This may include, to the extent that it is appropriate, the use of any of the features of one example embodiment being used in other embodiments. The invention's scope is, of course, defined in the language in which the appended claims are expressed.

Claims
  • 1. An implantable mean blood pressure sensor comprising: a housing configured to be implanted within a patient;a sensing component housed by the housing and exposed to a blood pressure exterior to the housing, wherein in response to the external blood pressure, the sensing component is configured to deform and maintain the deformation in a manner that maintains a mean pressure measurement of the external blood pressure over a period of time of at least one minute; andcircuitry operatively coupled to the sensing component and responsive to the deformation of the sensing component to produce a mean pressure signal that is representative of the mean pressure of the external pressure over the period of time.
  • 2. The implantable mean blood pressure sensor of claim 1, wherein the circuitry is configured to repeatedly receive an energy transfer from a remote source, and in response, transmit the mean pressure signal back to the remote source.
  • 3. The implantable mean blood pressure sensor of claim 1, wherein the sensing component is configured to deform and maintain the deformation in a manner that maintains the mean pressure measurement of the external pressure over the period of time without the application of electrical power.
  • 4. The implantable mean blood pressure sensor of claim 1, wherein the deformation of the sensing component has a time constant of at least one hour.
  • 5. The implantable mean blood pressure sensor of claim 1, wherein the deformation of the sensing component has a time constant of at least twelve hours.
  • 6. The implantable mean blood pressure sensor of claim 1, wherein the deformation of the sensing component has a time constant of at least 1 day.
  • 7. The implantable mean blood pressure sensor of claim 1, wherein the sensing component comprises: a first plate exposed to the external pressure exterior to the housing, the first plate configured to move in response to pressure changes within the external pressure;a second plate spaced apart from the first plate and disposed within the housing; anda viscoelastic material disposed between the first plate and the second plate.
  • 8. The implantable mean blood pressure sensor of claim 7, wherein the viscoelastic material comprises an electrically non-conductive material, and the mean pressure signal is representative of a capacitance between the first plate and the second plate.
  • 9. The implantable mean blood pressure sensor of claim 7, wherein the viscoelastic material comprises an electrically conductive material, and the mean pressure signal comprises an indication of a resistance between the first plate and the second plate.
  • 10. The implantable mean blood pressure sensor of claim 7, wherein the first plate is electrically conductive and the second plate is electrically conductive.
  • 11. The implantable mean blood pressure sensor of claim 1, wherein the sensing component comprises a hydraulic sensing component.
  • 12. The implantable mean blood pressure sensor of claim 11, wherein the hydraulic sensing component comprises: a hydraulic chamber exposed to the external pressure;a first fluid disposed within the hydraulic chamber;a pressure chamber;a second fluid disposed within the pressure chamber;a barrier disposed between the first fluid and the second fluid;wherein pressure changes in the hydraulic chamber relative to a pressure within the pressure chamber causes movement of the barrier.
  • 13. The implantable mean blood pressure sensor of claim 12, wherein the barrier comprises a low flow valve with a high permeability material.
  • 14. An implantable mean blood pressure sensor that is configured to provide a signal providing an indication of a mean blood pressure value over a period of time, the implantable mean blood pressure sensor comprising: a housing configured to be implanted in a patient; anda sensing component disposed within the housing yet exposed to an environment exterior to the housing, the sensing component configured to maintain a mean pressure measurement providing an indication of a mean pressure within the environment exterior to the housing over a period of time of at least one minute;wherein the sensing component maintains the mean pressure measurement without electrical energy.
  • 15. The implantable mean blood pressure sensor of claim 14, wherein the sensing component comprises a viscoelastic material having a time constant of at least one hour.
  • 16. A left atrial appendage closure device adapted to fit within a patient's left atrial appendage in order to substantially close off the patient's left atrial appendage, the left atrial appendage closure device comprising: expandable framework;a sensing component exposed to a left atrium pressure within the left atrium of the patient's heart once the left atrial appendage closure device is implanted, wherein in response to the left atrium pressure, the sensing component is configured to deform and maintain the deformation in a manner that maintains a mean pressure measurement of the left atrium pressure over a period of time of at least one minute; andcircuitry operatively coupled to the sensing component and responsive to the deformation of the sensing component to produce a mean pressure signal that is representative of the mean pressure of the left atrium pressure over the period of time.
  • 17. The left atrial appendage closure device of claim 16, wherein the sensing component comprises a viscoelastic material with a time constant of at least 10 minutes that, in response to the left atrium pressure, viscoelastically deforms in a manner that represents the mean pressure of the left atrium pressure over the period of time.
  • 18. The left atrial appendage closure device of claim 16, wherein the sensing component comprises a hydraulic system including a low flow valve, wherein in response to a positive change in the left atrium pressure, the sensing component moves fluid through the low flow valve under a hydraulic resistance in a first direction subject to a time constant of the sensing component defined at least in part by the low flow valve.
  • 19. The left atrial appendage closure device of claim 18, wherein in response to a negative change in the left atrium pressure, the sensing component moves fluid through the low flow valve in a second direction opposite to the first direction subject to the time constant of the sensing component.
CROSS REFERENCE TO RELATED APPLICATIONS

This application claims the benefit of U.S. Provisional Patent Application Ser. No. 63/119,337 filed on Nov. 30, 2020, the disclosure of which is incorporated herein by reference.

US Referenced Citations (609)
Number Name Date Kind
178283 French Jun 1876 A
1967318 Monahan Jul 1934 A
3402710 Paleschuck Sep 1968 A
3540431 Mobin-Uddin Nov 1970 A
3557794 Van Patten Jan 1971 A
3638652 Kelley Feb 1972 A
3811449 Gravlee et al. May 1974 A
3844302 Klein Oct 1974 A
3874388 King et al. Apr 1975 A
4007743 Blake Feb 1977 A
4108420 West et al. Aug 1978 A
4175545 Termanini Nov 1979 A
4309776 Berguer Jan 1982 A
4341218 Ü Jul 1982 A
4364392 Strother et al. Dec 1982 A
4425908 Simon Jan 1984 A
4545367 Tucci Oct 1985 A
4585000 Hershenson Apr 1986 A
4603693 Conta et al. Aug 1986 A
4611594 Grayhack et al. Sep 1986 A
4619246 Molgaard-Nielsen et al. Oct 1986 A
4638803 Rand et al. Jan 1987 A
4665906 Jervis May 1987 A
4681588 Ketharanathan et al. Jul 1987 A
4710192 Liotta et al. Dec 1987 A
4718417 Kittrell et al. Jan 1988 A
4759348 Cawood et al. Jul 1988 A
4781177 Lebigot Nov 1988 A
4793348 Palmaz Dec 1988 A
4827907 Tashiro May 1989 A
4832055 Palestrant May 1989 A
4873978 Ginsburg Oct 1989 A
4899751 Cohen Feb 1990 A
4917089 Sideris Apr 1990 A
4921484 Hillstead May 1990 A
4960412 Fink Oct 1990 A
4966150 Etienne et al. Oct 1990 A
4998972 Chin et al. Mar 1991 A
5037810 Saliba, Jr. Aug 1991 A
5041090 Scheglov et al. Aug 1991 A
5041093 Chu Aug 1991 A
5042707 Taheri Aug 1991 A
5053009 Herzberg Oct 1991 A
5064435 Porter Nov 1991 A
5071407 Termin et al. Dec 1991 A
5078736 Behl Jan 1992 A
5098440 Hillstead Mar 1992 A
5108418 Lefebvre Apr 1992 A
5108420 Marks Apr 1992 A
5108474 Riedy et al. Apr 1992 A
5116360 Pinchuk et al. May 1992 A
5122136 Guglielmi et al. Jun 1992 A
5129394 Mehra Jul 1992 A
5171259 Inoue Dec 1992 A
5171383 Sagaye et al. Dec 1992 A
5176692 Wilk et al. Jan 1993 A
5192301 Kamiya et al. Mar 1993 A
5211658 Clouse May 1993 A
5234458 Metais Aug 1993 A
5256146 Ensminger et al. Oct 1993 A
5258000 Gianturco Nov 1993 A
5258042 Mehta Nov 1993 A
5279539 Bohan et al. Jan 1994 A
5284488 Sideris Feb 1994 A
5304184 Hathaway et al. Apr 1994 A
5306234 Johnson Apr 1994 A
5312341 Turi May 1994 A
5329942 Gunther et al. Jul 1994 A
5334217 Das Aug 1994 A
5344439 Otten Sep 1994 A
5350398 Pavcnik et al. Sep 1994 A
5350399 Erlebacher et al. Sep 1994 A
5353784 Nady-Mohamed Oct 1994 A
5366460 Eberbach Nov 1994 A
5366504 Andersen et al. Nov 1994 A
5370657 Irie Dec 1994 A
5375612 Cottenceau et al. Dec 1994 A
5397331 Himpens et al. Mar 1995 A
5397355 Marin et al. Mar 1995 A
5409444 Kensey et al. Apr 1995 A
5417699 Klein et al. May 1995 A
5421832 Lefebvre Jun 1995 A
5425744 Fagan et al. Jun 1995 A
5427119 Swartz et al. Jun 1995 A
5433727 Sideris Jul 1995 A
5443454 Tanabe et al. Aug 1995 A
5443478 Purdy et al. Aug 1995 A
5451235 Lock et al. Sep 1995 A
5454365 Bonutti Oct 1995 A
5464408 Duc Nov 1995 A
5469867 Schmitt Nov 1995 A
5490856 Person et al. Feb 1996 A
5497774 Swartz et al. Mar 1996 A
5499975 Cope et al. Mar 1996 A
5499995 Teirstein Mar 1996 A
5522790 Voll et al. Jun 1996 A
5522822 Phelps et al. Jun 1996 A
5522836 Palermo Jun 1996 A
5527322 Klein et al. Jun 1996 A
5527338 Purdy Jun 1996 A
5558093 Pomeranz et al. Sep 1996 A
5558652 Henke Sep 1996 A
5569204 Cramer et al. Oct 1996 A
5591196 Marin et al. Jan 1997 A
5614204 Cochrum Mar 1997 A
5634936 Linden et al. Jun 1997 A
5634942 Chevillon et al. Jun 1997 A
5637097 Yoon Jun 1997 A
5643282 Kieturakis Jul 1997 A
5643292 Hart Jul 1997 A
5649953 Lefebvre Jul 1997 A
5653690 Booth et al. Aug 1997 A
5662671 Barbut et al. Sep 1997 A
5669933 Simon et al. Sep 1997 A
5681345 Euteneuer Oct 1997 A
5681347 Cathcart et al. Oct 1997 A
5683411 Kavteladze et al. Nov 1997 A
5690671 McGurk et al. Nov 1997 A
5693067 Purdy Dec 1997 A
5693886 Seimiya Dec 1997 A
5695525 Mulhauser et al. Dec 1997 A
5700285 Myers et al. Dec 1997 A
5702421 Schneidt Dec 1997 A
5704910 Humes Jan 1998 A
5709224 Behl et al. Jan 1998 A
5709704 Nott et al. Jan 1998 A
5709707 Lock et al. Jan 1998 A
5722400 Ockuly et al. Mar 1998 A
5724975 Negus et al. Mar 1998 A
5725512 Swartz et al. Mar 1998 A
5725552 Kotula et al. Mar 1998 A
5725568 Hastings Mar 1998 A
5733294 Forber et al. Mar 1998 A
5733302 Myler et al. Mar 1998 A
5735290 Sterman et al. Apr 1998 A
5749880 Banas et al. May 1998 A
5749883 Halpern May 1998 A
5749894 Engelson May 1998 A
5766219 Horton Jun 1998 A
5766246 Mulhauser et al. Jun 1998 A
5769816 Barbut et al. Jun 1998 A
5776097 Massoud Jul 1998 A
5776162 Kleshinski Jul 1998 A
5782860 Epstein et al. Jul 1998 A
5785679 Abolfathi et al. Jul 1998 A
5800454 Jacobsen et al. Sep 1998 A
5800457 Gelbfish Sep 1998 A
5800512 Letnz et al. Sep 1998 A
5807261 Benaron et al. Sep 1998 A
5810874 Lefebvre Sep 1998 A
5814028 Swartz et al. Sep 1998 A
5814029 Hassett Sep 1998 A
5814064 Daniel Sep 1998 A
5820591 Thompson et al. Oct 1998 A
5823198 Jones et al. Oct 1998 A
5830228 Knapp et al. Nov 1998 A
5833673 Ockuly et al. Nov 1998 A
5836913 Orth et al. Nov 1998 A
5836968 Simon et al. Nov 1998 A
5840027 Swartz et al. Nov 1998 A
5843118 Sepetka et al. Dec 1998 A
5846260 Maahs Dec 1998 A
5846261 Kotula et al. Dec 1998 A
5848969 Panescu et al. Dec 1998 A
5849005 Garrison et al. Dec 1998 A
5851232 Lois Dec 1998 A
5853422 Huebsch et al. Dec 1998 A
5855597 Jayaraman Jan 1999 A
5865791 Whayne et al. Feb 1999 A
5865802 Yoon et al. Feb 1999 A
5868702 Stevens et al. Feb 1999 A
5868708 Hart et al. Feb 1999 A
5876367 Kaganov et al. Mar 1999 A
5879296 Ockuly et al. Mar 1999 A
5879366 Shaw et al. Mar 1999 A
5882340 Yoon Mar 1999 A
5885258 Sachdeva et al. Mar 1999 A
5891558 Bell et al. Apr 1999 A
5895399 Barbut et al. Apr 1999 A
5902289 Swartz et al. May 1999 A
5904680 Kordis et al. May 1999 A
5904703 Gilson May 1999 A
5906207 Shen May 1999 A
5910154 Tsugita et al. Jun 1999 A
5911734 Tsugita et al. Jun 1999 A
5916236 Muijs Van de Moer et al. Jun 1999 A
5925060 Forber Jul 1999 A
5925063 Khosravi Jul 1999 A
5925074 Gingras et al. Jul 1999 A
5925075 Myers et al. Jul 1999 A
5928192 Maahs Jul 1999 A
5928260 Chin et al. Jul 1999 A
5931818 Werp et al. Aug 1999 A
5935145 Villar et al. Aug 1999 A
5935147 Kensey et al. Aug 1999 A
5935148 Villar et al. Aug 1999 A
5941249 Maynard Aug 1999 A
5941896 Kerr Aug 1999 A
5944738 Amplatz et al. Aug 1999 A
5947997 Pavcnik et al. Sep 1999 A
5951589 Epstein et al. Sep 1999 A
5951599 McCrory Sep 1999 A
5954694 Sunseri Sep 1999 A
5954767 Pajotin et al. Sep 1999 A
5957940 Tanner et al. Sep 1999 A
5961545 Entz et al. Oct 1999 A
5976174 Ruiz Nov 1999 A
5980514 Kupiecki et al. Nov 1999 A
5980555 Barbut et al. Nov 1999 A
5989281 Barbut et al. Nov 1999 A
5993469 McKenzie et al. Nov 1999 A
5993483 Gianotti Nov 1999 A
5997557 Barbut et al. Dec 1999 A
6004280 Buck et al. Dec 1999 A
6004348 Banas et al. Dec 1999 A
6007523 Mangosong Dec 1999 A
6007557 Ambrisco et al. Dec 1999 A
6010517 Baccaro Jan 2000 A
6010522 Barbut et al. Jan 2000 A
6013093 Nott et al. Jan 2000 A
6024751 Lovato et al. Feb 2000 A
6024754 Engelson Feb 2000 A
6024755 Addis Feb 2000 A
6024756 Huebsch et al. Feb 2000 A
6027520 Tsugita et al. Feb 2000 A
6033420 Hahnen Mar 2000 A
6036720 Abrams et al. Mar 2000 A
6042598 Tsugita et al. Mar 2000 A
6048331 Tsugita et al. Apr 2000 A
6051014 Jang Apr 2000 A
6051015 Maahs Apr 2000 A
6056720 Morse May 2000 A
6063070 Eder May 2000 A
6063113 Kavteladze et al. May 2000 A
6066126 Li et al. May 2000 A
6068621 Balceta et al. May 2000 A
6074357 Kaganov et al. Jun 2000 A
6076012 Swanson et al. Jun 2000 A
6079414 Roth Jun 2000 A
6080182 Shaw et al. Jun 2000 A
6080183 Tsugita et al. Jun 2000 A
6083239 Addis Jul 2000 A
6090084 Hassett et al. Jul 2000 A
6096052 Callister et al. Aug 2000 A
6096053 Bates et al. Aug 2000 A
6110243 Wnenchak et al. Aug 2000 A
6123715 Amplatz Sep 2000 A
6124523 Banas et al. Sep 2000 A
6132438 Fleischman et al. Oct 2000 A
6135991 Muni et al. Oct 2000 A
6136016 Barbut et al. Oct 2000 A
6139527 Laufer et al. Oct 2000 A
6139573 Sogard et al. Oct 2000 A
6152144 Lesh et al. Nov 2000 A
6152946 Broome et al. Nov 2000 A
6156055 Ravenscroft Dec 2000 A
6159195 Ha et al. Dec 2000 A
6161543 Cox et al. Dec 2000 A
6168615 Ken et al. Jan 2001 B1
6171329 Shaw et al. Jan 2001 B1
6179859 Bates et al. Jan 2001 B1
6193739 Chevillon et al. Feb 2001 B1
6203531 Ockuly et al. Mar 2001 B1
6206907 Marino et al. Mar 2001 B1
6214029 Thill et al. Apr 2001 B1
6221092 Koike et al. Apr 2001 B1
6231561 Frazier et al. May 2001 B1
6231589 Wessman et al. May 2001 B1
6235045 Barbut et al. May 2001 B1
6245012 Kleshinski Jun 2001 B1
6251122 Tsukernik Jun 2001 B1
6258115 Dubrul Jul 2001 B1
6267772 Mulhauser et al. Jul 2001 B1
6267776 O'Connell Jul 2001 B1
6270490 Hahnen Aug 2001 B1
6270530 Eldridge et al. Aug 2001 B1
6270902 Tedeschi et al. Aug 2001 B1
6277138 Levinson et al. Aug 2001 B1
6285898 Ben-Haim Sep 2001 B1
6290674 Roue et al. Sep 2001 B1
6290708 Kugel et al. Sep 2001 B1
6312407 Zadno-Azizi et al. Nov 2001 B1
6319251 Tu et al. Nov 2001 B1
6328727 Frazier et al. Dec 2001 B1
6328755 Marshall Dec 2001 B1
6342062 Suon et al. Jan 2002 B1
6346116 Brooks et al. Feb 2002 B1
6346895 Lee et al. Feb 2002 B1
6361545 Macoviak et al. Mar 2002 B1
6364895 Greenhalgh Apr 2002 B1
6368338 Kónya et al. Apr 2002 B1
6371971 Tsugita et al. Apr 2002 B1
6375670 Greenhalgh Apr 2002 B1
6391044 Yadav et al. May 2002 B1
6398803 Layne et al. Jun 2002 B1
6402746 Whayne et al. Jun 2002 B1
6402771 Palmer et al. Jun 2002 B1
6402779 Colone et al. Jun 2002 B1
6419669 Frazier et al. Jul 2002 B1
6440152 Gainor et al. Aug 2002 B1
6443972 Bosma et al. Sep 2002 B1
6447530 Ostrovsky et al. Sep 2002 B1
6454775 Demarais et al. Sep 2002 B1
6458145 Ravenscroft et al. Oct 2002 B1
6464712 Epstein et al. Oct 2002 B1
6468291 Bates et al. Oct 2002 B2
6468301 Amplatz et al. Oct 2002 B1
6485501 Green Nov 2002 B1
6488689 Kaplan et al. Dec 2002 B1
6511496 Huter et al. Jan 2003 B1
6514280 Gilson Feb 2003 B1
6517573 Pollock et al. Feb 2003 B1
6533782 Howell et al. Mar 2003 B2
6547760 Samson et al. Apr 2003 B1
6547815 Myers Apr 2003 B2
6551303 Van Tassel et al. Apr 2003 B1
6551344 Thill Apr 2003 B2
6558401 Azizi May 2003 B1
6558405 McInnes May 2003 B1
6558414 Layne May 2003 B2
6562058 Seguin et al. May 2003 B2
6569184 Huter May 2003 B2
6569214 Williams et al. May 2003 B2
6589214 McGuckin et al. Jul 2003 B2
6589251 Yee et al. Jul 2003 B2
6599308 Amplatz Jul 2003 B2
6602271 Adams et al. Aug 2003 B2
6623508 Shaw et al. Sep 2003 B2
6641564 Kraus Nov 2003 B1
6650923 Lesh et al. Nov 2003 B1
6652555 VanTassel et al. Nov 2003 B1
6652556 VanTassel et al. Nov 2003 B1
6666861 Grabek Dec 2003 B1
6689150 Vantassel et al. Feb 2004 B1
6699260 Dubrul et al. Mar 2004 B2
6699276 Sogard et al. Mar 2004 B2
6702825 Frazier et al. Mar 2004 B2
6712836 Berg et al. Mar 2004 B1
6726701 Gilson et al. Apr 2004 B2
6730108 Van Tassel et al. May 2004 B2
6755812 Peterson et al. Jun 2004 B2
6827737 Hill et al. Dec 2004 B2
6837901 Rabkin et al. Jan 2005 B2
6855153 Saadat Feb 2005 B2
6911037 Gainor et al. Jun 2005 B2
6932838 Schwartz et al. Aug 2005 B2
6942653 Quinn Sep 2005 B2
6949113 Van Tassel et al. Sep 2005 B2
6958061 Truckai et al. Oct 2005 B2
6994092 van der Burg et al. Feb 2006 B2
7011671 Welch Mar 2006 B2
7014645 Greene, Jr. et al. Mar 2006 B2
7037321 Sachdeva et al. May 2006 B2
7044134 Khairkhahan et al. May 2006 B2
7097651 Harrison et al. Aug 2006 B2
7128073 van der Burg et al. Oct 2006 B1
7137953 Eigler et al. Nov 2006 B2
7152605 Khairkhahan et al. Dec 2006 B2
7169164 Borillo et al. Jan 2007 B2
7179275 McGuckin, Jr. et al. Feb 2007 B2
7226466 Opolski Jun 2007 B2
7303526 Sharkey et al. Dec 2007 B2
7317951 Schneider et al. Jan 2008 B2
7323002 Johnson et al. Jan 2008 B2
7344505 Stofer et al. Mar 2008 B2
7484403 Baroni et al. Feb 2009 B2
7597704 Frazier et al. Oct 2009 B2
7678123 Chanduszko Mar 2010 B2
7695425 Schweich et al. Apr 2010 B2
7713282 Frazier et al. May 2010 B2
7722641 van der Burg et al. May 2010 B2
7727189 VanTassel et al. Jun 2010 B2
7735493 van der Burg et al. Jun 2010 B2
7780694 Palmer et al. Aug 2010 B2
7799049 Ostrovsky et al. Sep 2010 B2
7811300 Feller, III et al. Oct 2010 B2
7811314 Fierens et al. Oct 2010 B2
7862500 Khairkhahan et al. Jan 2011 B2
7927365 Fierens et al. Apr 2011 B2
7972359 Kreidler Jul 2011 B2
8025495 Hardert et al. Sep 2011 B2
8043329 Khairkhahan et al. Oct 2011 B2
8052715 Quinn et al. Nov 2011 B2
8062282 Kolb Nov 2011 B2
8080032 van der Burg et al. Dec 2011 B2
8097015 Devellian Jan 2012 B2
8100938 Figulla et al. Jan 2012 B2
8142363 Eigler et al. Mar 2012 B1
8221384 Frazier et al. Jul 2012 B2
8221445 van Tassel et al. Jul 2012 B2
8287563 Khairkhahan et al. Oct 2012 B2
8323309 Khairkhahan et al. Dec 2012 B2
8388672 Khairkhahan et al. Mar 2013 B2
8491623 Vogel et al. Jul 2013 B2
8523897 van Der Burg et al. Sep 2013 B2
8535343 van Der Burg et al. Sep 2013 B2
8562509 Bates Oct 2013 B2
8663273 Khairkhahan et al. Mar 2014 B2
8685055 VanTassel et al. Apr 2014 B2
8728117 Janardhan et al. May 2014 B1
8758389 Glimsdale Jun 2014 B2
8828051 Javois et al. Sep 2014 B2
8834519 van der Burg et al. Sep 2014 B2
8845711 Miles et al. Sep 2014 B2
9034006 Quinn et al. May 2015 B2
9132000 VanTassel et al. Sep 2015 B2
9168043 van Der Burg et al. Oct 2015 B2
9211124 Campbell et al. Dec 2015 B2
9295472 Ottma Mar 2016 B2
9351716 Miles et al. May 2016 B2
9445895 Kreidler Sep 2016 B2
9554804 Erzbeger Jan 2017 B2
9554806 Larsen et al. Jan 2017 B2
9561037 Fogarty et al. Feb 2017 B2
9561097 Kim et al. Feb 2017 B1
9592058 Erzbeger et al. Mar 2017 B2
9597088 Ottma Mar 2017 B2
9629636 Fogarty et al. Apr 2017 B2
9730701 Tischler et al. Aug 2017 B2
9743932 Amplatz et al. Aug 2017 B2
9750505 Miles et al. Sep 2017 B2
9763666 Wu et al. Sep 2017 B2
9795387 Miles et al. Oct 2017 B2
9808253 Li et al. Nov 2017 B2
9883936 Sutton et al. Feb 2018 B2
9913652 Bridgeman et al. Mar 2018 B2
9943299 Khairkhahan et al. Apr 2018 B2
9943315 Kaplan et al. Apr 2018 B2
10071181 Penegor et al. Sep 2018 B1
10076335 Zaver et al. Sep 2018 B2
10143458 Kreidler Dec 2018 B2
10201337 Glimsdale Feb 2019 B2
10231737 Amplatz et al. Mar 2019 B2
20010000797 Mazzocchi May 2001 A1
20010020181 Layne Sep 2001 A1
20010034537 Shaw et al. Oct 2001 A1
20010037141 Yee et al. Nov 2001 A1
20020022860 Borillo et al. Feb 2002 A1
20020035374 Borillo et al. Mar 2002 A1
20020045931 Sogard et al. Apr 2002 A1
20020062133 Gilson et al. May 2002 A1
20020082638 Porter et al. Jun 2002 A1
20020082675 Myers Jun 2002 A1
20020099439 Schwartz et al. Jul 2002 A1
20020111647 Khairkhahan et al. Aug 2002 A1
20020138094 Borillo et al. Sep 2002 A1
20020138097 Ostrovsky et al. Sep 2002 A1
20020169475 Gainor et al. Nov 2002 A1
20020177855 Greene, Jr. et al. Nov 2002 A1
20030017775 Dong et al. Jan 2003 A1
20030023262 Welch Jan 2003 A1
20030023266 Borillo et al. Jan 2003 A1
20030055345 Figler et al. Mar 2003 A1
20030057156 Peterson et al. Mar 2003 A1
20030060871 Hill et al. Mar 2003 A1
20030120337 Van Tassel et al. Jun 2003 A1
20030130581 Salo et al. Jul 2003 A1
20030181942 Sutton et al. Sep 2003 A1
20030191526 Van Tassel et al. Oct 2003 A1
20030195555 Khairkhahan et al. Oct 2003 A1
20030199923 Khairkhahan et al. Oct 2003 A1
20030204203 Khairkhahan et al. Oct 2003 A1
20030208214 Loshakove et al. Nov 2003 A1
20030212432 Khairkhahan et al. Nov 2003 A1
20030220667 van der Burg et al. Nov 2003 A1
20040034366 van der Burg et al. Feb 2004 A1
20040044361 Frazier et al. Mar 2004 A1
20040049210 VanTassel et al. Mar 2004 A1
20040093012 Cully et al. May 2004 A1
20040098031 van der Burg et al. May 2004 A1
20040122467 VanTassel et al. Jun 2004 A1
20040127935 VanTassel et al. Jul 2004 A1
20040147969 Mann Jul 2004 A1
20040158274 WasDyke Aug 2004 A1
20040186486 Roue et al. Sep 2004 A1
20040215230 Frazier et al. Oct 2004 A1
20040220610 Kreidler et al. Nov 2004 A1
20040220682 Levine et al. Nov 2004 A1
20040230222 van der Burg et al. Nov 2004 A1
20050004641 Pappu Jan 2005 A1
20050004652 van der Burg et al. Jan 2005 A1
20050015109 Lichtenstein Jan 2005 A1
20050038470 van der Burg et al. Feb 2005 A1
20050049573 Van Tassel et al. Mar 2005 A1
20050070952 Devellian Mar 2005 A1
20050113861 Corcoran et al. May 2005 A1
20050125020 Meade et al. Jun 2005 A1
20050177182 van der Burg et al. Aug 2005 A1
20050203568 Burg et al. Sep 2005 A1
20050283186 Berrada et al. Dec 2005 A1
20050288596 Figler et al. Dec 2005 A1
20050288704 Cartier et al. Dec 2005 A1
20060015136 Besselink Jan 2006 A1
20060030877 Martinez et al. Feb 2006 A1
20060052816 Bates et al. Mar 2006 A1
20060100658 Obana et al. May 2006 A1
20060155323 Porter et al. Jul 2006 A1
20060247680 Amplatz et al. Nov 2006 A1
20070066993 Kreidler Mar 2007 A1
20070083227 van der Burg et al. Apr 2007 A1
20070083230 Javois Apr 2007 A1
20070112380 Figulla et al. May 2007 A1
20070150041 Evans et al. Jun 2007 A1
20070156123 Moll et al. Jul 2007 A1
20070162048 Quinn et al. Jul 2007 A1
20070185471 Johnson Aug 2007 A1
20070255112 Taepke, II et al. Nov 2007 A1
20080275536 Zarins et al. Nov 2008 A1
20090005803 Batiste Jan 2009 A1
20090062841 Amplatz et al. Mar 2009 A1
20090099647 Glimsdale et al. Apr 2009 A1
20090105747 Chanduszko et al. Apr 2009 A1
20090112249 Miles et al. Apr 2009 A1
20090254195 Khairkhan et al. Oct 2009 A1
20090312650 Maile et al. Dec 2009 A1
20090318948 Linder et al. Dec 2009 A1
20100004726 Hancock et al. Jan 2010 A1
20100049238 Simpson Feb 2010 A1
20100106178 Obermiller et al. Apr 2010 A1
20100324585 Miles et al. Dec 2010 A1
20110054515 Bridgeman et al. Mar 2011 A1
20110082495 Ruiz Apr 2011 A1
20110098525 Kermode et al. Apr 2011 A1
20110152698 Greenhut Jun 2011 A1
20110218566 van der Burg et al. Sep 2011 A1
20110301630 Hendriksen et al. Dec 2011 A1
20120029553 Quinn et al. Feb 2012 A1
20120035643 Khairkhahan et al. Feb 2012 A1
20120065662 van der Burg et al. Mar 2012 A1
20120125619 Wood et al. May 2012 A1
20120172654 Bates Jul 2012 A1
20120172927 Campbell et al. Jul 2012 A1
20120239077 Zaver et al. Sep 2012 A1
20120239083 Kreidler Sep 2012 A1
20120245619 Guest Sep 2012 A1
20120271337 Figulla et al. Oct 2012 A1
20120283585 Werneth et al. Nov 2012 A1
20120283773 Van Tassel et al. Nov 2012 A1
20120323267 Ren Dec 2012 A1
20130006343 Kassab et al. Jan 2013 A1
20130012982 Khairkhahan et al. Jan 2013 A1
20130018413 Oral et al. Jan 2013 A1
20130110154 van der Burg et al. May 2013 A1
20130131717 Glimsdale May 2013 A1
20130165735 Khairkhahan et al. Jun 2013 A1
20130165801 Min Jun 2013 A1
20130211492 Schneider et al. Aug 2013 A1
20130296912 Ottma Nov 2013 A1
20130331884 Van der Burg et al. Dec 2013 A1
20130338686 Ruiz Dec 2013 A1
20140005714 Quick et al. Jan 2014 A1
20140018841 Peiffer et al. Jan 2014 A1
20140039536 Cully et al. Feb 2014 A1
20140046360 van der Burg et al. Feb 2014 A1
20140081314 Zaver et al. Mar 2014 A1
20140100596 Rudman et al. Apr 2014 A1
20140142612 Li et al. May 2014 A1
20140148842 Khairkhahan et al. May 2014 A1
20140163605 VanTassel et al. Jun 2014 A1
20140188157 Clark Jul 2014 A1
20140214077 Glimsdale Jul 2014 A1
20140296908 Ottma et al. Oct 2014 A1
20140303719 Cox et al. Oct 2014 A1
20140336612 Frydlewski et al. Nov 2014 A1
20140336699 van der Burg et al. Nov 2014 A1
20140364941 Edmiston et al. Dec 2014 A1
20150005810 Center et al. Jan 2015 A1
20150039021 Khairkhahan et al. Feb 2015 A1
20150080903 Dillard et al. Mar 2015 A1
20150196300 Tischler et al. Jul 2015 A1
20150230909 Zaver et al. Aug 2015 A1
20150238197 Quinn et al. Aug 2015 A1
20150305727 Karimov et al. Oct 2015 A1
20150313604 Roue et al. Nov 2015 A1
20150313605 Griffin Nov 2015 A1
20150327979 Quinn et al. Nov 2015 A1
20150374491 Kreidler Dec 2015 A1
20160015397 Figulla et al. Jan 2016 A1
20160051358 Sutton et al. Feb 2016 A1
20160058539 VanTassel et al. Mar 2016 A1
20160066922 Bridgeman et al. Mar 2016 A1
20160106437 van der Burg et al. Apr 2016 A1
20160192942 Strauss et al. Jul 2016 A1
20160287259 Hanson et al. Oct 2016 A1
20160331382 Center et al. Nov 2016 A1
20160374657 Kreidler Dec 2016 A1
20170007262 Amplatz et al. Jan 2017 A1
20170027552 Turkington et al. Feb 2017 A1
20170042550 Chakraborty et al. Feb 2017 A1
20170056166 Ratz et al. Mar 2017 A1
20170065191 Jayaraman et al. Mar 2017 A1
20170100112 van der Burg et al. Apr 2017 A1
20170119400 Amplatz et al. May 2017 A1
20170181751 Larsen et al. Jun 2017 A1
20170340336 Osypka Nov 2017 A1
20170354421 Maguire et al. Dec 2017 A1
20180064446 Figulla et al. Mar 2018 A1
20180070950 Zaver et al. Mar 2018 A1
20180110468 Goldshtein et al. Apr 2018 A1
20180140412 Sutton et al. May 2018 A1
20180140413 Quinn et al. May 2018 A1
20180186622 Mögelin et al. Jul 2018 A1
20180250014 Melanson et al. Sep 2018 A1
20180369594 Werneth et al. Dec 2018 A1
20190133563 Glimsdale May 2019 A1
20190175185 Amplatz et al. Jun 2019 A1
20190223883 Anderson et al. Jul 2019 A1
20190247053 Inouye Aug 2019 A1
20190336135 Inouye et al. Nov 2019 A1
Foreign Referenced Citations (82)
Number Date Country
1399571 Feb 2003 CN
202143640 Feb 2012 CN
104287804 Jan 2015 CN
104352261 Feb 2015 CN
106859722 Jun 2017 CN
10964173 Mar 2019 CN
10201004476 Mar 2012 DE
1523957 Apr 2005 EP
1595504 Nov 2005 EP
1463561 Jul 2008 EP
2074953 Jan 2009 EP
2481381 Aug 2012 EP
2928420 Oct 2015 EP
3072461 Sep 2016 EP
3372173 Sep 2018 EP
3398523 Nov 2018 EP
2003532457 Nov 2003 JP
2005324019 Nov 2005 JP
2007503286 Feb 2007 JP
2007513684 May 2007 JP
2009160402 Jul 2009 JP
2012501793 Jan 2012 JP
2016539698 Dec 2016 JP
9313712 Jul 1993 WO
9504132 Feb 1995 WO
9522359 Aug 1995 WO
9601591 Jan 1996 WO
9640356 Dec 1996 WO
9721402 Jun 1997 WO
9726939 Jul 1997 WO
9728749 Aug 1997 WO
9735522 Oct 1997 WO
9802100 Jan 1998 WO
9817187 Apr 1998 WO
9822026 May 1998 WO
9823322 Jun 1998 WO
9827868 Jul 1998 WO
9905977 Feb 1999 WO
9907289 Feb 1999 WO
9908607 Feb 1999 WO
9923976 May 1999 WO
9925252 May 1999 WO
9930640 Jun 1999 WO
9944510 Sep 1999 WO
9959479 Nov 1999 WO
0001308 Jan 2000 WO
0016705 Mar 2000 WO
0027292 May 2000 WO
0035352 Jun 2000 WO
0053120 Sep 2000 WO
0067669 Nov 2000 WO
0108743 Feb 2001 WO
0115629 Mar 2001 WO
0121247 Mar 2001 WO
0126726 Apr 2001 WO
0130266 May 2001 WO
0130267 May 2001 WO
0130268 May 2001 WO
0170119 Sep 2001 WO
0215793 Feb 2002 WO
0224106 Mar 2002 WO
02071977 Sep 2002 WO
03007825 Jan 2003 WO
03008030 Jan 2003 WO
03032818 Apr 2003 WO
2004012629 Feb 2004 WO
2007044536 Apr 2007 WO
2010024801 Mar 2010 WO
2010081033 Jul 2010 WO
2013060855 May 2013 WO
2013159065 Oct 2013 WO
2014011865 Jan 2014 WO
2014018907 Jan 2014 WO
2014089129 Jun 2014 WO
201406239 Jul 2014 WO
2015080991 Jun 2015 WO
2015164836 Oct 2015 WO
2016087145 Jun 2016 WO
2018017935 Jan 2018 WO
2018024866 Feb 2018 WO
2018187732 Oct 2018 WO
2019084358 May 2019 WO
Non-Patent Literature Citations (43)
Entry
International Search Report and Written Opinion dated Aug. 3, 2004 for International Application No. PCT/US2004/008109.
International Search Report and Written Opinion dated Feb. 15, 2000 for International Application No. PCT/US99/26325.
International Search Report dated May 20, 2003 for International Application No. PCT/US02/33808.
Written Opinion dated Nov. 17, 2003 for International Application No. PCT/US/02/33808.
International Search Report and Written Opinion dated Aug. 21, 2018 for International Application No. PCT/US2018/029684.
Cragg et al., “A New Percutaneous Vena Cava Filter,” American Journal of Radiology, Sep. 1983, pp. 601-604, vol. 141.
Cragg et al, “Nonsurgical Placement of Arterial Endoprostheses: A New Technique Using Nitinol Wire,” Radiology, Apr. 1983, pp. 261-263, vol. 147, No. 1.
Lock et al., “Transcatheter Closure of Atrial Septal Defects.” Circulation, May 1989, pp. 1091-1099, vol. 79, No. 5.
Lock et al., “Transcatheter Umbrella Closure of Congenital Heart Defects,” Circulation, Mar. 1987, pp. 593-599, vol. 75, No. 3.
Rashkind et al., “Nonsurgical closure of patent ductus arteriosus: clinical application of the Rashkind PDA Occluder System,” Circulation, Mar. 1987, pp. 583-592, vol. 75, No. 3.
Rosengart et al., “Percutaneous and Minimally Invasive Valve Procedures,” Circulation, Apr. 1, 2008, pp. 1750-1767, vol. 117.
Ruttenberg, “Nonsurgical Therapy of Cardiac Disorders,” Pediatric Consult, 1986, Pages not numbered, vol. 5, No. 2.
Sugita et al., “Nonsurgical Implantations of a Vascular Ring Prosthesis Using Thermal Shape Memory Ti/Ni Alloy (Nitinol Wire),” Trans. Am. Soc. Artif. Intern. Organs, 1986, pp. 30-34, vol. XXXII.
Wessel et al., “Outpatient Closure of the Patent Ductus Arteriousus,” Circulation, 1988, pp. 1068-1071, vol. 77, No. 5.
Tung et al., U.S. Appl. No. 61/559,941, filed Nov. 15, 2011.
Yue Yu et al., U.S. Appl. No. 61/557,880, filed Dec. 20, 2011.
Cline, “File: Fish hooks.jpg,” Wikipedia foundation , Inc., San Francisco, CA, Jun. 2007; p. 1 of 4; available online at http://en.wikipedia.org/wiki/File:Fish_hooks.jpg; last accessed Oct. 5, 2012.
International Search Report and Written Opinion dated Apr. 22, 2014 for International Application No. PCT/US2013/078454.
Aryana et al., “Incomplete Closure of the Left Atrial Appendage: Implication and Management.” Curr Cardiol Rep., 18(9):82, 2016.
Delurgio, “Device-Associated Thrombus and Peri-Device Leak Following Left Atrial Appendage Closure with the Amplatzer Cardiac Plug.” JACC: Cardiovascular Interventions, 10(4): 400-402, 2017.
University of Minnesota. Atlas of Human Cardiac Anatomy, Left Atrium. Retrieved from http://www.vhlab.umn.edu/atlas/left-atrium/left-atrial-appendage/index.shtml. Accessed 2017. Downloaded 2019.
Saw et al., “Incidence and Clinical Impact of Device-Associated Thrombus and Peri-Device Leak following Left Atrial Appendage Closure with the Amplatzer Cardiac Plug.” JACC: Cardiovascular Intervention. 10(4): 391-399, 2017.
Romero et al., “Left Atrial Appendage Closure Devices,” Clinical Medicine Insights: Cardiology, vol. 8, pp. 45-52, 2014.
Invitation To Pay Additional Fees And, Where Applicable, Protest Fee, mailed Oct. 13, 2016.
International Search Report and Written Opinion dated Oct. 14, 2019 for International Application No. PCT/US2019/047452.
International Search Report and Written Opinion dated Oct. 27, 2017 for International Application No. PCT/US2017/048150.
International Search Report and Written Opinion dated Jan. 21, 2019 for International Application No. PCT/US2018/051953.
International Search Report and Written Opinion dated Oct. 13, 2016 for International Application No. PCT/US2016/043363.
International Search Report and Written Opinion dated Mar. 17, 2020, for International Application No. PCT/US2019/065243.
International Search Report and Written Opinion dated Sep. 9, 2019 for International Application No. PCT/US2019/033698.
Blackshear et al; “Appendage Obliteration to Reduce Stroke in Cardiac Surgical Patients with Atrial Fibrillation”, Ann. Thoracic Surgery, pp. 755-759, 1996.
Lindsay, “Obliteration of the Left Atrial Appendage: A Concept Worth Testing”, Ann. Thoracic Surgery, 1996.
Invitation To Pay Additional Fees dated Feb. 22, 2019 for International Application No. PCT/US2018/066163.
International Search Report and Written Opinion dated Oct. 23, 2020 for International Application No. PCT/US2020/042192.
International Search Report and Written Opinion dated Mar. 24, 2022 for International Application No. PCT/US2021/060990.
International Search Report and Written Opinion dated Oct. 13, 2020 for International Application No. PCT/US2020/048437.
International Search Report and Written Opinion dated Jul. 15, 2021 for International Application No. PCT/US2021/023687.
10 Viscoelasticity Document, 60 pages, 2021.
10.2 Examples and Applications of Viscoelastic Materials, 3 pages, 2021.
Boutry et al; “Fully Biodegradable Pressure Sensor, Viscoelastic Behavior of PGS Dielectric Elastomer upon Degradation”, IEEE, 4 pages, Authorized Licensed limited to Boston Scientific Corporation. Downloaded on Nov. 30, 2020 from IEEE Xplore.
Hwang et al; “Unveiling Viscoelastic Response of Capacitive-Type Pressure Sensor by Controlling Cross-Linking Density and Surface Structure of Elastomer,” ACS Appl. Polym. Mater. 2,6, pp. 2190-2198, 2020.
Tsai et al; “On-Chip Pressure Sensor using Single-Layer Concentric Chambers,” Biomicrofluidics, 10, 11 pages, AIP Publishing, 2016.
Viscoelasticity, Wikipedia, 2020. https://wikipedia.org/wiki/Viscoelasticity.
Related Publications (1)
Number Date Country
20220167861 A1 Jun 2022 US
Provisional Applications (1)
Number Date Country
63119337 Nov 2020 US